iGan Partners

iGan Partners is a prominent healthcare-focused venture capital firm based in Toronto, Canada, dedicated to transforming global healthcare through strategic investments. The firm partners with exceptional founders who are commercializing and scaling technological advancements in the healthcare sector. They provide not only early-stage capital but also active support and access to a robust network of industry partners and co-investors, aiming to foster the growth and success of their portfolio companies.

Founded in 2011 by Sam Ifergan, iGan Partners emerged with a mission to empower visionary entrepreneurs. The firm focuses on building companies for the long-term, creating a supportive ecosystem that includes capital, talent, and management experience to help startups and scale-ups reach their full potential. They primarily invest in Seed to Series A stage companies, offering follow-on funding through to exit, with a keen interest in disruptive sectors such as AI-enabled MedTech and Digital Health.

iGan Partners has built a notable portfolio of companies that exemplify its commitment to healthcare innovation. Key investments include Cosm Medical, a medical device company modernizing pelvic health; Exact Imaging, which focuses on advanced imaging technologies; MolecuLight, dedicated to bringing innovative wound care technology to clinicians; and Flosonics Medical, developing disruptive technology for healthcare delivery. The firm seeks innovations that significantly improve patient outcomes and substantially reduce overall healthcare costs.

The iGan Partners team comprises experienced entrepreneurs, company builders, operators, and investors, bringing a unique blend of expertise and domain-specific knowledge to their investments. Led by Founder & Managing Partner Sam Ifergan and Chief Medical Officer Dr. Lorena Tora, the team also includes Venture Partners Billy Lai and Joel Finlayson, Director of Investment & Portfolio Management Wendi Zhao, HR Office Manager Anita Nunes, and Investment and Operations Analyst David Ifergan. This diverse team provides valuable strategic guidance and operational support to their portfolio companies, leveraging their deep understanding of the healthcare and technology landscapes.